EPIGRAL.BO
Epigral Limited$1,135.95
Jun 02, 2026
Revenue · FY
$25.27B
Net income
$3.32B
FY 2026
EPS · diluted
$76.95
EBITDA
$5.67B
Explain this page
Arphra AIPlain-English read on Epigral Limited’s valuationComposite rating
—
Consensus
—
Target consensus
—
Recent activity
—
Last 30 days
No ratings snapshot in DB for this symbol yet.
No grades consensus available.
Peer comparables
Green = best, red = worst (per column)| Ticker | Mcap | P/E | P/S | EV/EBITDA | ROE | D/E | Div Yield |
|---|---|---|---|---|---|---|---|
EPIGRAL.BOEpigral LimitedFocus | — | — | — | — | — | — | — |
Analyst grade actions — 5 years
Stacked monthly countsNo analyst-grade actions in
analyst_grades for EPIGRAL.BO over the last 5 years.